Emergency MedicineHaematologySurgery
Major Haemorrhage / Massive Transfusion
Major Haemorrhage / Massive Transfusion clinical pathway.
Source: BCSH; RCOA; RCEM; RCS — BCSH Guidelines
Step 1 of ~4
info
Activation
Assessment:
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Methylene Blue · Guanylate Cyclase / Nitric Oxide Pathway Inhibitor
- Alteplase (tPA) · Thrombolytic — Ischaemic Stroke / Massive PE
- Sodium phenylbutyrate · Ammonia scavenger (alternative pathway)
- Marstacimab · Anti-tissue factor pathway inhibitor (TFPI) monoclonal antibody
- Glasdegib (Specialist drug) · Hedgehog pathway inhibitor
- Vismodegib (Specialist drug) · Hedgehog pathway (SMO) inhibitor
Pathways
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
- Syncope Assessment · ESC 2018 Syncope Guidelines; NICE NG109
- Acute Chest Pain · NICE CG95; ESC 2023 ACS Guidelines
Decision support only. Always apply local guidelines and clinical judgement.